New developments in the management of chronic lymphocytic leukemia: role of ofatumumab
Luca Laurenti,1 Idanna Innocenti,1 Francesco Autore,1 Simona Sica,1 Dimitar G Efremov2 1Department of Hematology, Catholic University of the Sacred Heart, Rome, 2Molecular Hematology, International Centre for Genetic Engineering and Biotechnology, Monterotondo, Italy Abstract: Ofatumumab is one o...
Main Authors: | Laurenti L, Innocenti I, Autore F, Sica S, Efremov DG |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/new-developments-in-the-management-of-chronic-lymphocytic-leukemia-rol-peer-reviewed-article-OTT |
Similar Items
-
Assessment of the efficacy of ofatumumab in patients with chronic lymphocytic leukaemia treated in the Department of Haematooncology and Bone Marrow Transplantation of the Medical University in Lublin – Prelimary results
by: Ewa Wąsik-Szczepanek, et al.
Published: (2018-03-01) -
Refractory pemphigus vulgaris successfully treated with ofatumumab
by: Daniel M. Klufas, MD, et al.
Published: (2020-08-01) -
Ofatumumab – a valid treatment option for chronic lymphocytic leukemia patients
by: AlDallal SM
Published: (2017-07-01) -
Novel Immunotherapeutic Strategies for Chronic Lymphocytic Leukemia
by: Beckwith, Kyle Addison
Published: (2016) -
CD20 mAb-Mediated Complement Dependent Cytotoxicity of Tumor Cells is Enhanced by Blocking the Action of Factor I
by: Margaret A. Lindorfer, et al.
Published: (2013-11-01)